Phase 1 Study to Evaluate the Safety and the Pharmacokinetics of NVP-2203 in Healthy Adult Volunteers
Latest Information Update: 17 Jan 2024
At a glance
- Drugs NVP-2203 (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacokinetics
- Sponsors NVP Healthcare
- 09 Jan 2024 Status changed from not yet recruiting to completed.
- 20 Feb 2023 New trial record